| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 1997;28:1944-1947.)
© 1997 American Heart Association, Inc.
Articles |
From the Department of Radiology and Nuclear Medicine, Akita Research Institute of Brain and Blood Vessels (J.H., E.S., T.S., H.T., T.O), and Department of Psychiatry, University of Tokyo Faculty of Medicine (T.S.) (Japan).
| Abstract |
|---|
|
|
|---|
Methods A positron emission tomographic study with H215O, C15O, and 15O2 was performed in eight normal control subjects without any WML (mean±1 SD age, 68.5±10.2 years) and in 15 asymptomatic subjects with WML (71.3±8.5 years) to measure regional cerebral blood flow (CBF), cerebral blood volume, oxygen extraction fraction (OEF), and oxygen metabolic rate.
Results In the cerebral white matter in the asymptomatic subjects with WML, significantly lower CBF (20.3±3.9 mL/100 mL per minute; P<.05) and significantly higher OEF (0.43±0.08; P<.05) were found compared with those for control subjects (23.5±2.6 mL/100 mL per minute and 0.37±0.06, respectively). The severity of WML was not related to the magnitude of hypoperfusion. In the basal ganglia, significantly lower CBF (44.9±6.9 mL/100 mL per minute; P<.01) and significantly higher OEF (0.54±0.08; P<.01) were found in the WML group than in control subjects (70.1±12.0 mL/100 mL/min and 0.39±0.03, respectively). In the thalamus, there was no significant difference in CBF and OEF between the control and WML groups.
Conclusions Hypoperfusion of the cerebral white matter and basal ganglia in asymptomatic WML subjects may be induced by the arteriosclerosis of long penetrating medullary arteries and lenticulostriate arteries but may not be directly related to the production of WML. The role of hypoperfusion in the production of WML and acceleration of its development remains to be elucidated.
Key Words: cerebral blood flow magnetic resonance imaging metabolism tomography, emission computed white matter
| Introduction |
|---|
|
|
|---|
| Subjects and Methods |
|---|
|
|
|---|
Evaluation of MR Images
MR imaging was performed with the use of a 0.5-T whole-body
scanner (Magnex; Shimadzu Co). T1-weighted and T2-weighted transaxial
images were obtained with the use of a gradient-echo pulse sequence
with TR of 300 ms and TE of 9 ms and a spin-echo pulse sequence with TR
of 3000 ms and TE of 90 ms. Seventeen transaxial images parallel to the
bicommissural line were obtained with 5-mm center-to-center spacing.
The three-dimensional MR angiographic data were obtained by a
time-of-flight technique with gradient-echo imaging. The technical
parameters were as follows: TR, 40 ms; TE, 8 ms; flip
angle, 25°; single excitation; matrix size, 256x180; field of view,
25 cm; and slab, 64 mm. The effective slice thickness was 1
mm.
MR images were reviewed independently by two neuroradiologists (E.S. and J.H.). In each subject, the location, appearance, number, and size of hyperintense lesions on each T2-weighted MR image were evaluated. Eight of the 23 subjects (6 men and 2 women) showed neither WML nor basal ganglia lesions on T2-weighted MR images. They were defined as a control group. Their ages ranged from 49 to 82 years (mean±1 SD, 68.5±10.2 years). These eight subjects were neither hypertensive nor diabetic. Two male subjects had a history of cigarette smoking for more than 10 years.
In the other 15 subjects (11 men and 4 women), punctate or patchy WML
were found in the subcortical and/or deep
supratentorial white matter with various other
lesions. These subjects were defined as the WML group. The severity of
punctate or patchy WML was graded as follows: mild, focal WML limited
to one region of the brain; moderate, multiple WML extending beyond one
region; and severe, confluent WML forming multiple patches. Their ages
ranged from 50 to 82 years (mean±1 SD, 71.3±8.5 years). Of these 15
subjects, two were hypertensive under medication. Two subjects were
diagnosed as having diabetes mellitus and were treated by diet. Two
subjects had both hypertension medicated orally and diabetes treated by
diet. Five subjects were cigarette smokers with more than a 10-year
history. Patient profiles are summarized in Table 1
.
|
PET Measurements
PET images were acquired with a whole-body four-ring,
seven-slice positron tomograph (Headtome IV, Shimadzu Co). The CBF,
CMRO2, and CBV were measured by administering
H215O,7 and by delivering inhaled
15O28 and
C15O,9 respectively. All the PET images were
obtained parallel to the bicommissural line. The detailed procedures
for setting the scan slice and the quantification of
physiological parameters were
previously described elsewhere.10
The arterial partial pressures of O2 and CO2, hematocrit, and pH were measured in a blood gas tension analyzer (IL-1303, Instrumental Laboratory). The arterial hemoglobin concentration was measured with a hemoglobin analyzer (MLK-1100, NIHON KODEN Ltd). There was no significant difference between the mean values of these physiological parameters in the control subjects and those in the subjects with WML. Systemic arterial blood pressure and heart rate were monitored with a 2300 Finapress blood pressure monitor (Omeda) during the study.
The functional data were transferred to a conventional Unix work station system (TITAN 750, Kubota Computer). A fully automatic multimodality image registration algorithm11 was applied to the MR and PET images in each subject. The circular regions of interest, each with a 16-mm diameter, were manually placed in the caudate nucleus, lentiform nucleus, thalamus, corona radiata, and centrum semiovale on the MR images. The PET measures were read by the use of predetermined regions of interest on MR images superimposed on the PET images. The measures for basal ganglia were defined as an average of the values for the caudate nucleus and lentiform nucleus. The values for cerebral white matter were calculated by averaging the values for corona radiata and centrum semiovale. In each subject, the mean measures were obtained by averaging the values for both hemispheres. The Wilcoxon-Mann-Whitney test for small sample size was used for the statistical analysis.
Results
Table 2
summarizes the mean
values of CBF, CBV, OEF, and CMRO2 in the cerebral white
matter, basal ganglia, and thalamus for the control subjects and
asymptomatic subjects with WML. In the cerebral white
matter in the latter group, the mean CBF was significantly decreased
(P<.05), and the mean OEF was significantly increased
(P<.05) compared with the control value. The mean
CMRO2 was not significantly different from the control
value. The cerebral white matter CBF for the subgroups of mild (n=6),
moderate (n=4), and severe WML (n=5) was 18.9±3.0, 21.8±1.4, and
21.0±5.4 mL/100 mL per minute, respectively. There was no significant
difference among the subgroups.
|
In the basal ganglia, the CBF for the asymptomatic WML group was significantly decreased compared with that in the control subjects (P<.01), the OEF was significantly increased (P<.01), and the CMRO2 value was not significantly different. In the thalamus, no significant differences from the control values in these measures were found in the asymptomatic WML group.
The Figure
demonstrates the T2-weighted
images (left), CBF (center), and CMRO2 (right) images at
the level of the basal ganglia for a control subject (top row) and an
asymptomatic subject with WML (bottom row).
|
| Discussion |
|---|
|
|
|---|
We speculated on several mechanisms responsible for the hypoperfusion in the cerebral white matter. We observed that the CMRO2 in the cerebral white matter was not significantly altered in the WML group. Therefore, this hypoperfusion may not be induced by the metabolic inactivation of the white matter. In the WML subjects, we did not find steno-occlusive arterial disease of the internal carotid artery and main trunks of cerebral arteries on MR angiography. This suggested that the hypoperfusion was not due to steno-occlusive disease of the carotid arteries and major cerebral arteries.
The cerebral white matter is supplied by long penetrating medullary arteries and partly by lenticulostriate arteries. Furuta et al12 found that the sclerotic changes of the medullary artery advanced with age and correlated well with the presence of ischemic white matter changes in 110 autopsied brains from nonneuropsychiatric subjects. The histopathological studies in asymptomatic subjects with WML revealed that punctate or patchy MR lesions were often associated with a variety of arteriosclerotic changes in arterioles and ischemic damage of the brain parenchyma.13 14 15 16 17 These pathological studies indicated that the cerebral white matter hypoperfusion associated with asymptomatic WML would probably be due to subclinical sclerosis of medullary arteries and arterioles.
It is noteworthy that the basal ganglia CBF was reduced in the asymptomatic WML group. We tentatively subdivided the asymptomatic WML subjects into two subgroups with and without basal ganglia lesions depicted on MR images. There was no significant difference in the mean basal ganglia CBF, OEF, and CMRO2 between the two subgroups. Our results suggested that arteriosclerosis of perforating arteries may coexist with that of medullary arteries and may induce hypoperfusion in its territory regardless of the presence of basal ganglia lesions on MR imaging.
The blood flow in the thalamus was not significantly altered in the asymptomatic subjects with WML. This structure is supplied by thalamoperforating arteries that primarily belong to the vertebrobasilar system. Since the cerebral white matter is supplied by medullary arteries and lenticulostriate arteries, the presence of the WML in the cerebral white matter may be independent of thalamic blood flow. Collateral channels of lenticulostriate arteries are rare,18 but thalamoperforating arteries have rich collaterals to each other.19 The different collateral potential may contribute to the CBF difference between the basal ganglia and thalamus in the subjects with WML.
It is still unclear whether hypoperfusion of the cerebral white matter is a primary cause of the production of WML. When decreased CBF is directly related to WML, the more severe hypoperfusion may result in the greater production of WML. We preliminarily analyzed the relationship between the magnitude of hypoperfusion and the severity of WML. However, we failed to find a significant difference in the cerebral white matter CBF between the subgroups with mild and severe WML. In addition, there was no asymmetrical CBF even though the WML was predominantly located in the unilateral hemisphere. These observations suggested that the hypoperfusion of cerebral white matter may not be directly related to the production of WML. The role of hypoperfusion in the production of WML and acceleration of its development remains to be elucidated.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
| Footnotes |
|---|
Received February 24, 1997; revision received July 2, 1997; accepted July 2, 1997.
| References |
|---|
|
|
|---|
2.
Lechner H, Schmidt R, Bertha G, Justich E, Offenbecher
H, Schneider G. Nuclear magnetic resonance imaging white matter
lesions and risk factors for stroke in normal individuals.
Stroke. 1988;19:263-265.
3.
Ylikoski A, Erkinjuntti T, Raininko R, Sarna S,
Sulkava R, Tilvis R. White matter hyperintensities on MRI in the
neurologically nondiseased elderly: analysis of cohorts of
consecutive subjects aged 55 to 85 years living at home.
Stroke. 1995;26:1171-1177.
4. Meguro K, Hatazawa J, Yamaguchi T, Itoh M, Matsuzawa T, Ono S, Miyazawa H, Hishinuma T, Yanai K, Sekita Y, Yamada K. Cerebral circulation and oxygen metabolism associated with subcortical periventricular hyperintensity as shown by magnetic resonance imaging. Ann Neurol. 1990;28:378-383.[Medline] [Order article via Infotrieve]
5.
Kobayashi S, Okada K, Yamashita K. Incidence of
silent lacunar lesion in normal adults and its relation to cerebral
blood flow and risk factors. Stroke. 1991;22:1379-1383.
6. Isaka Y, Okamoto M, Ashida K, Imaizumi M. Decreased cerebrovascular dilatory capacity in subjects with asymptomatic periventricular hyperintensities. Stroke. 1994;25:375-381.[Abstract]
7.
Herscovitch P, Markham J, Raichle ME. Brain
blood flow measured with intravenous
H215O, I: theory and error
analysis. J Nucl Med. 1983;24:782-789.
8.
Raichle ME, Martin WRW, Herscovitch P, Mintun MA,
Markham J. Brain blood flow measured with
intravenous H215O, II:
implementation and validation. J Nucl Med. 1983;24:790-798.
9.
Mintun MA, Raichle ME, Martin WRW, Herscovitch
P. Brain oxygen utilization measured with O-15 radiotracers and
positron emission tomography. J Nucl Med. 1984;25:177-187.
10. Hatazawa J, Fujita H, Kanno I, Satoh T, Iida H, Miura S, Murakami M, Okudera T, Inugami A, Ogawa T, Shimosegawa E, Kyo Noguchi, Shohji Y, Uemura K. Regional cerebral blood flow, blood volume, oxygen extraction fraction, and oxygen utilization rate in normal volunteers measured by the autoradiographic technique and the single breath inhalation method. Ann Nucl Med. 1995;9:15-21.[Medline] [Order article via Infotrieve]
11. Ardekani B, Braun M, Hutton BF, Kanno I, Iida H. A fully automatic multimodality image registration algorithn. J Comput Assist Tomogr. 1995;19:615-623.[Medline] [Order article via Infotrieve]
12.
Furuta A, Ishii N, Nishihara Y, Horie A.
Medullary arteries in aging and dementia. Stroke. 1991;22:442-446.
13.
Awad IA, Johnson P, Spetzler RF, Hodak JA.
Incidental subcortical lesions identified on magnetic resonance imaging
in the elderly, II: postmortem pathological correlations.
Stroke. 1986;17:1090-1097.
14. Braffman BH, Zimmerman RA, Trojanowski JQ, Gonatas NK, Hickey WF, Schaepfer WW. Brain MR: pathologic correlation with gross and histology, II: hyperintense white-matter foci in the elderly. AJNR Am J Neuroradiol. 1988;9:629-636.
15.
Marchall VG, Bradley WG, Marshall CE, Bhoopat T, Rhodes
RH. Deep white matter infarction: correlation of MR imaging and
histopathologic findings. Radiology. 1988;167:517-522.
16. Fazekas F, Kleinert R, Offenbacher H, Payer F, Schmidt R, Kleinert G, Radner H, Lechner H. The morphologic correlate of incidental punctate white matter hyperintensities on MR images. AJNR Am J Neuroradiol.. 1990;12:915-921.[Abstract]
17.
Chimowitz MI, Estes ML, Furlan AI, Awad IA.
Further observation on the pathology of subcortical lesions identified
on magnetic resonance imaging. Arch Neurol. 1992;49:747-752.
18. Rosner SS, Rhoton Jr AL, Ono M, Barry M. Microsurgical anatomy of the anterior perforating arteries. J Neurosurg. 1984;61:468-485.[Medline] [Order article via Infotrieve]
19.
Marinkovic SV, Milisavljevic M, Kovacevic MS.
Anastomoses among the thalamoperforating branches of the posterior
cerebral artery. Arch Neurol. 1986;43:811-814.
This article has been cited by other articles:
![]() |
T.J. Huynh, B. Murphy, J.A. Pettersen, H. Tu, D.J. Sahlas, L. Zhang, S.P. Symons, S. Black, T.-Y. Lee, and R.I. Aviv CT Perfusion Quantification of Small-Vessel Ischemic Severity AJNR Am. J. Neuroradiol., November 1, 2008; 29(10): 1831 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Wiseman, B. K. Saxby, E. J. Burton, R. Barber, G. A. Ford, and J. T. O'Brien Hippocampal atrophy, whole brain volume, and white matter lesions in older hypertensive subjects Neurology, November 23, 2004; 63(10): 1892 - 1897. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. van der Grond, A. F. van Raamt, Y. van der Graaf, W. P.T.M. Mali, and R. H.C. Bisschops A fetal circle of Willis is associated with a decreased deep white matter lesion load Neurology, October 26, 2004; 63(8): 1452 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Atwood, P. A. Wolf, N. L. Heard-Costa, J. M. Massaro, A. Beiser, R. B. D'Agostino, and C. DeCarli Genetic Variation in White Matter Hyperintensity Volume in the Framingham Study Stroke, July 1, 2004; 35(7): 1609 - 1613. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Waldstein, E. L. Siegel, D. Lefkowitz, K. J. Maier, J. R. Pelletier Brown, A. M. Obuchowski, and L. I. Katzel Stress-Induced Blood Pressure Reactivity and Silent Cerebrovascular Disease Stroke, June 1, 2004; 35(6): 1294 - 1298. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Harbison, G. J. Gibson, D. Birchall, I. Zammit-Maempel, and G. A. Ford White matter disease and sleep-disordered breathing after acute stroke Neurology, October 14, 2003; 61(7): 959 - 963. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yoshikawa, K. Murase, N. Oku, M. Imaizumi, M. Takasawa, P. Rishu, Y. Kimura, Y. Ikejiri, K. Kitagawa, M. Hori, et al. Heterogeneity of Cerebral Blood Flow in Alzheimer Disease and Vascular Dementia AJNR Am. J. Neuroradiol., August 1, 2003; 24(7): 1341 - 1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yoshikawa, K. Murase, N. Oku, K. Kitagawa, M. Imaizumi, M. Takasawa, T. Nishikawa, M. Matsumoto, J. Hatazawa, and M. Hori Statistical Image Analysis of Cerebral Blood Flow in Vascular Dementia with Small-Vessel Disease J. Nucl. Med., April 1, 2003; 44(4): 505 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O'Sullivan, D. J. Lythgoe, A. C. Pereira, P. E. Summers, J. M. Jarosz, S. C.R. Williams, and H. S. Markus Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis Neurology, August 13, 2002; 59(3): 321 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.R. Marstrand, E. Garde, E. Rostrup, P. Ring, S. Rosenbaum, E.L. Mortensen, and H.B.W. Larsson Cerebral Perfusion and Cerebrovascular Reactivity Are Reduced in White Matter Hyperintensities Stroke, April 1, 2002; 33(4): 972 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mungas, W. J. Jagust, B. R. Reed, J. H. Kramer, M. W. Weiner, N. Schuff, D. Norman, W. J. Mack, L. Willis, and H. C. Chui MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease Neurology, December 26, 2001; 57(12): 2229 - 2235. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Fein, V. Di Sclafani, J. Tanabe, V. Cardenas, M. W. Weiner, W. J. Jagust, B. R. Reed, D. Norman, N. Schuff, L. Kusdra, et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease Neurology, December 12, 2000; 55(11): 1626 - 1635. [Abstract] [Full Text] [PDF] |
||||
![]() |
H S Markus, D J Lythgoe, L Ostegaard, M O'Sullivan, and S C R Williams Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI J. Neurol. Neurosurg. Psychiatry, July 1, 2000; 69(1): 48 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Steffens, M. J. Helms, K. R. R. Krishnan, and G. L. Burke Cerebrovascular Disease and Depression Symptoms in the Cardiovascular Health Study Stroke, October 1, 1999; 30(10): 2159 - 2166. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. M. Bakker, F.-E. de Leeuw, J. C. de Groot, A. Hofman, P. J. Koudstaal, and M. M. B. Breteler Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly Neurology, February 1, 1999; 52(3): 578 - 578. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |